Shijiazhuang Yiling Pharmaceutical Co. Ltd
Quick facts
Phase 3 pipeline
- Felbinac Trometamol Injection · Pain Management / Rheumatology
Felbinac trometamol is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation. - XY0206 · Diabetes
XY0206 is a small molecule that targets the SGLT2 receptor.
Phase 2 pipeline
Phase 1 pipeline
- [14C]XY0206
- Bio-008
- Phenlarmide · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: